241 results on '"Furuta, Yousuke"'
Search Results
2. Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection
3. Use of Favipiravir to Treat Lassa Virus Infection in Macaques
4. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
5. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment
6. Analysis of the responsible site for favipiravir resistance in RNA-dependent RNA polymerase of influenza virus A/PR/8/34 (H1N1) using site-directed mutagenesis
7. Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV
8. Favipiravir (T-705), a novel viral RNA polymerase inhibitor
9. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy
10. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
11. T-705 (Favipiravir) Activity against Lethal H5N1 Influenza a Viruses
12. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus
13. Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models
14. Air-Launch Experiment Using Suspended Rail Launcher for Rockoon
15. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
16. Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus
17. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
18. M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening
19. Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice
20. Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus
21. Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques
22. In Vitro and In Vivo Efficacy of Combinational Therapy with Favipiravir (T-705) and Oseltamivir Against Influenza A/CA/04/09 Pandemic H1N1 Virus: 41
23. Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
24. Effect of T-705 treatment on western equine encephalitis in a mouse model
25. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
26. Efficacy of T-1106 or T-705, Alone or in Combination with Ribavirin, in the Treatment of Hamsters Infected with Yellow Fever Virus: 46
27. In Vitro and In Vivo Activity of T-705 Against Arenavirus and Bunyavirus Infections: 40
28. No significant enhancement of protection by Tat-expressing Sendai viral vector-booster in a macaque AIDS model
29. Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis
30. Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice
31. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir
32. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
33. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice
34. Favipiravir (T-705) protects against Nipah virus infection in the hamster model
35. Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients
36. Favipiravir effect against rabies infection
37. Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir
38. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir
39. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
40. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir
41. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses
42. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
43. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
44. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever
45. Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
46. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus
47. Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
48. Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
49. A cell-based screening system for influenza A viral RNA transcription/replication inhibitors
50. Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.